Dupilumab for treatment of severe atopic dermatitis accompanied by lichenoid amyloidosis in adults: Two case reports

Figure 2 Skin lesions at various follow-up time points of patient 2 after application of dupilumab to the lesions. A: Skin lesions of hands before the treatment of dupilumab; B: Skin lesions of both lower limbs before the treatment of dupilumab; C: 16-wk follow-up; D: 16-wk follow-up; E: Hands 1.5 year post-treatment follow-up; F: Lower limbs 1.5 years post-treatment follow-up.